机构：[1]Chongqing Key Laboratory of Biochemistry and Molecular Pharmacology,[2]Department of Anatomy,The first Affiliated Hospital of Chongqing Medical University重庆医科大学附属第一医院[3]Department of Pharmacy, The first Affiliated Hospital of Chongqing Medical University重庆医科大学附属第一医院[4]Department of Pharmacology,Chongqing Medical University, Chongqing, China[5]Department of Pathophysiology, Chongqing Medical University, Chongqing, China
第一作者机构：[1]Chongqing Key Laboratory of Biochemistry and Molecular Pharmacology,
通讯作者：
推荐引用方式(GB/T 7714)：
Wan J. -Y.,Gong X.,Luo F. -L.,et al.HESPERIDIN ATTENUATES LIPOPOLYSACCHARIDE-INDUCED FULMINANT HEPATIC FAILURE IN D-GALACTOSAMINE-SENSITIZED MICE[J].JOURNAL OF HEPATOLOGY.2010,52:S385-S385.doi:10.1016/S0168-8278(10)60998-1.
APA：
Wan, J. -Y.,Gong, X.,Luo, F. -L.,Li, H. -Z.&Zhang, L..(2010).HESPERIDIN ATTENUATES LIPOPOLYSACCHARIDE-INDUCED FULMINANT HEPATIC FAILURE IN D-GALACTOSAMINE-SENSITIZED MICE.JOURNAL OF HEPATOLOGY,52,
MLA：
Wan, J. -Y.,et al."HESPERIDIN ATTENUATES LIPOPOLYSACCHARIDE-INDUCED FULMINANT HEPATIC FAILURE IN D-GALACTOSAMINE-SENSITIZED MICE".JOURNAL OF HEPATOLOGY 52.(2010):S385-S385
医学